Knockout of CD5 on CAR T Cells Boosts Anti-Tumor Efficacy
July 20, 2024
July 20, 2024
UNIVERSITY CITY, Pennsylvania, July 20 (TNSres) -- The University of Pennsylvania's Perelman School of Medicine issued the following news release:
* * *
Penn Medicine researchers identify CD5 as an immune checkpoint protein and a potential target of future cancer therapies
* * *
PHILADELPHIA - The effectiveness of CAR T cell therapy against a variety of cancers, including solid tumors, could be boosted greatly by using CRISPR-Cas9 technology to . . .
* * *
Penn Medicine researchers identify CD5 as an immune checkpoint protein and a potential target of future cancer therapies
* * *
PHILADELPHIA - The effectiveness of CAR T cell therapy against a variety of cancers, including solid tumors, could be boosted greatly by using CRISPR-Cas9 technology to . . .